Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

NCT05700084 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Utidelone Capsule (Part 1)
DRUG: Drug A Utidelone Capsule (Part 2: Group A-B)
DRUG: Drug A Utidelone Capsule (Part 2: Group B-A)
DRUG: Drug B Utidelone Injection (Part 2: Group A-B)
DRUG: Drug B Utidelone Injection (Part 2: Group B-A)
DRUG: Capecitabine
DRUG: Utidelone Capsule (Part 3)

Sponsor

Beijing Biostar Pharmaceuticals Co., Ltd.